Skip to main content
logo
Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.6051
+0.0151 (2.56%)
Jan 8, 2026, 1:21 PM EST - Market open

Outlook Therapeutics Revenue

In the fiscal year ending September 30, 2025, Outlook Therapeutics had annual revenue of $1.41M. Outlook Therapeutics had revenue of $-91.79K in the quarter ending September 30, 2025.

Revenue (ttm)
$1.41M
Revenue Growth
n/a
P/S Ratio
14.52
Revenue / Employee
$83,149
Employees
17
Market Cap
38.80M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Sep 30, 20251.41M--
Sep 30, 2024---
Sep 30, 2023---
Sep 30, 2022---
Sep 30, 2021---
Sep 30, 2020---
Sep 30, 20198.15M5.06M163.84%
Sep 30, 20183.09M-723.96K-18.99%
Sep 30, 20173.81M831.94K27.92%
Sep 30, 20162.98M-2.24M-42.91%
Sep 30, 20155.22M-3.83M-42.33%
Sep 30, 20149.05M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

OTLK News

More News